BIM
RARX

BlackRock Investment Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

BlackRock Investment Management’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$169K Buy
+11,099
New +$151K ﹤0.01% 3240

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BlackRock Investment Management's RARX Position: Q4 2016 in Review

BlackRock Investment Management opened a new position in Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q4 2016: 11,099 shares worth $169K. The stake represents ﹤0.01% of the portfolio and ranks #3240 among its holdings.

59 funds tracked by Wall St. Rank hold RARX as of Q4 2016.

  • BlackRock Investment Management held 11,099 shares of Ra Pharmaceuticals, Inc. Common Stock worth $169K as of Q4 2016.
  • Ra Pharmaceuticals, Inc. Common Stock was a new BlackRock Investment Management position in Q4 2016.
  • Ra Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3240 holding.
  • 59 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.